GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1201 - 1225 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 1 10 moderate
G24617OK
399
IgA Patient 1 22 moderate
G24617OK
408
IgA Patient 1 6 moderate
G24617OK
337
IgG Patient 1 10 moderate
G24617OK
24
IgG Patient 1 22 moderate
G24617OK
31
IgG Patient 1 6 moderate
G24617OK
26
IgM Patient 1 10 moderate
G24617OK
55
IgM Patient 1 22 moderate
G24617OK
143
IgA Patient 2 15 mild
G24617OK
424
IgA Patient 2 24 mild
G24617OK
519
IgG Patient 2 15 mild
G24617OK
71
IgG Patient 2 24 mild
G24617OK
69
IgM Patient 2 15 mild
G24617OK
124
IgM Patient 2 24 mild
G24617OK
156
IgM Patient 1 6 moderate
G24617OK
43
IgA Patient 2 3 mild
G24617OK
492
IgG Patient 2 3 mild
G24617OK
78
IgM Patient 2 3 mild
G24617OK
174
IgA Patient 3 -180 mild
G24617OK
3775
IgA Patient 3 11 mild
G24617OK
3123
IgG Patient 3 -180 mild
G24617OK
2836
IgM Patient 3 -180 mild
G24617OK
11712
IgA Patient 3 4 mild
G24617OK
3765
IgG Patient 3 11 mild
G24617OK
2427
IgG Patient 3 4 mild
G24617OK
2856

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024